Publications

Chan J, Gidding H, Blyth CC, Fathima P, Jayasinghe S, McIntyre PB, Moore HC, Mulholland K, Nguyen CD, Andrews R, Russell FM. Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: an observational study. PLOS Medicine. 2021;18:e1003733. doi: 10.1371/journal.pmed.1003733. eCollection. [Full text]

Homaira N, Binks M, Walker G, Larter N, Clark K, Campbell M, Briggs N, Yiro JN, Stelzer-Braid S, Hu N, Macartney K, Snelling T, Omer S, Andrews R, Jaffe A. Transplacental transfer of RSV antibody in Australian First Nations infants. Journal of Medical Virology. 2022;94:782-86. https://doi.org/10.1002/jmv.27383 . [Abstract]

Leask J, Carlson S, Attwell K, Clark K, Kaufman J, Frawley J, Cashman P, Seale H, Bolsewicz K, Steffens M, Danchin M. COVID-19 vaccination: recommendations from the Collaboration on Social Science in Immunisation. Medical Journal of Australia. 2021;215: 9-12.e1. doi: 10.5694/mja2.51136. [Full text]

Makenga G, Mtove G, Mziray A, Bwana V, Kisinza W, Mjema J, Amos B, Antony L, Oftadeh S, Yin KJ, Shingadia D, Booy R. Immunogenicity and efficacy of pneumococcal conjugate vaccine (Prevenar13®) in preventing acquisition of carriage of pneumococcal vaccine serotypes in Tanzanian children with HIV/AIDS. Frontiers in Immunology. 2021;12:673392 . [Full text]

Quesada MG, Yang Y, Bennett JC, Hayford K, Zeger SL, Feikin DR, Peterson M, Cohen AL, Almeida SCG, Ampofo K, Ang M, Bar-Zeev N, Bruce NG, Cameron C, Camilli R, Chacón GC, Ciruela P, Cohen C, Corcoran M, Dagan R, De Wals P, Desmet S, Guevara M, Hamm. Serotype distribution of remaining pneumococcal meningitis in the mature PCV10/13 period: findings from the PSERENADE Project. Microorganisms. 2021;9:738. doi: 10.3390/microorganisms9040738. [Abstract]

Bennett JC, Hetrich M, Quesada MG, Sinkevitch J, Knoll MD, Feikin DR, Zeger SL, Kagucia EW, Cohen AL, Ampofo K, Brandileone MC, Bruden D, Camilli R, Castilla J, Chan G, Ciruela P, Cook H, Cornick JE, Dagan R, Danis K, de Miguel S, De Wals P, Desme. Changes in serotype 1 invasive pneumococcal disease following introduction of PCV10 and PCV13: findings from the PSERENADE Project. Microorganisms. 2021;9:696. doi: 10.3390/microorganisms9040696. [Abstract]

Tuckerman J, Blyth C, Beard F, Danchin M. COVID-19 and the 2020 National Immunisation Program changes present a unique opportunity to optimise the Australian Immunisation Register. Medical Journal of Australia. 2021;214:247-249.e1. doi: 10.5694/mja2.50971. [Full text]

Abdi I, Gidding H, Leong RN, Moore HC, Seale H, Menzies R. Vaccine coverage in children born to migrant mothers in Australia: a population-based cohort study. Vaccine. 2021; 39:984-993 . [Full text]

Gidding HF, Machalek DA, Hendry A, Quinn HE, Vette K, Beard F, Shilling H, Hirani R, Gosbell IB, Irving DO, Hueston L, Downes M, Carlin JB, O’Sullivan MVN, Dwyer DE, Kaldor J, Macartney K. Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020. Medical Journal of Australia. 3 February 2021. [Full text]

McVernon J, Fielding J, Sullivan S, Beard F, Macartney K, Williams J, Dawson A, Gilbert G, Massey P, Crooks K, Moss R, McCaw J. Constructing an ethical framework for priority allocation of pandemic influenza vaccines. Vaccine. 2021;39:797-804 doi: 10.1016/j.vaccine.2020.12.053. [Full text]